Characterization of the novel HLA-DRB3*02:179N allele by sequencing-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
12 2022
Historique:
received: 29 07 2022
accepted: 02 08 2022
pubmed: 5 8 2022
medline: 19 11 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

HLA-DRB3*02:179N differs from DRB3*02:02:01:02 by one nucleotide substitution in codon 98 in exon 3.

Identifiants

pubmed: 35922968
doi: 10.1111/tan.14754
pmc: PMC9804616
doi:

Substances chimiques

HLA-DRB3 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-659

Informations de copyright

© 2022 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.

Références

Tissue Antigens. 2010 Apr;75(4):291-455
pubmed: 20356336
HLA. 2020 Jan;95(1):30-39
pubmed: 31577866
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
HLA. 2022 Dec;100(6):658-659
pubmed: 35922968

Auteurs

Marine Cargou (M)

Laboratoire d'Immunologie et Immunogénétique, CHU de Bordeaux, Bordeaux, France.
University Bordeaux, CNRS, ImmunoConcEpT, Bordeaux, France.

Marco Andreani (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.

Tiziana Galluccio (T)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.

Lucie Blandin (L)

Laboratoire d'Immunologie et Immunogénétique, CHU de Bordeaux, Bordeaux, France.

Jonathan Visentin (J)

Laboratoire d'Immunologie et Immunogénétique, CHU de Bordeaux, Bordeaux, France.
University Bordeaux, CNRS, ImmunoConcEpT, Bordeaux, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH